7-141919488-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001656.3(OR9A4):āc.613T>Cā(p.Phe205Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001656.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR9A4 | NM_001001656.3 | c.613T>C | p.Phe205Leu | missense_variant | 2/2 | ENST00000641559.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR9A4 | ENST00000641559.1 | c.613T>C | p.Phe205Leu | missense_variant | 2/2 | NM_001001656.3 | P1 | ||
OR9A4 | ENST00000548136.1 | c.613T>C | p.Phe205Leu | missense_variant | 1/1 | P1 | |||
MGAM | ENST00000465654.5 | c.-180+11620T>C | intron_variant | 3 | |||||
MGAM | ENST00000497554.1 | n.37-10289T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250064Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135638
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727242
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2023 | The c.613T>C (p.F205L) alteration is located in exon 1 (coding exon 1) of the OR9A4 gene. This alteration results from a T to C substitution at nucleotide position 613, causing the phenylalanine (F) at amino acid position 205 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at